Minoxidil
This article was originally published in The Tan Sheet
Executive Summary
Foam delivery system for OTC hair loss treatment ingredient under development, Palo Alto, Calif.-based Connetics says in teleconference March 21. Firm may commercialize product itself or seek marketing partners; Rogaine marketer Pharmacia says it currently has no interest in alternative delivery forms. Connetics also developing foam delivery for ketoconazole 2% and plans to file an NDA during first half of 2002 upon completing clinical trial this year; the 2% dose (McNeil's Rx Nizoral) recently was associated with hair loss benefits, prompting McNeil to investigate a new indication (1"The Tan Sheet" March 12, p. 3). Connetics acquired Victoria, Australia-based Soltec Research for $16.9 mil. in cash March 20. Soltec developed a mousse delivery form for Bayer's Rid pediculicide approved March 2000